Patent Assignment
Reel/Frame 072960/0788
Assignment of Assignor's Interest
Recorded: 2025-11-19
Pages: 15
Assignor
OMGA LIQUIDATING, INC. (F/K/A OMEGA THERAPEUTICS, INC.)
Executed: 2025-04-25
Assignee
FLAGSHIP LABS 114, INC. (F/K/A PIONEERING MEDICINES 08-B, INC.)
55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Methods and Compositions for Modulating Methylation of a Target Gene
Application:
19/484,267 →
Methods and Compositions for Modulating PCSK9 Expression
Application:
19/484,264 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 19, 2025
From: MORRISON-SMITH, CHEVAUN DANIELLE; FARELLI, JEREMIAH D.; CHEN, JUSTIN; O'DONNELL, CHARLES W.
To: OMEGA THERAPEUTICS, INC.
Reel/Frame 072959/0430 →
Assignment of Assignor's Interest
Nov 19, 2025
From: MORRISON-SMITH, CHEVAUN DANIELLE; FARELLI, JEREMIAH D.; O'DONNELL, CHARLES W.
To: OMEGA THERAPEUTICS, INC.
Reel/Frame 072959/0483 →
Change of Name
Feb 5, 2026
From: FLAGSHIP LABS 114, INC.
To: SEPIA THERAPEUTICS, INC.
Reel/Frame 074719/0247 →